{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:08:31Z","timestamp":1784531311838,"version":"3.55.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC-2024-2790136"],"award-info":[{"award-number":["RC-2024-2790136"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.path.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:06:41Z","timestamp":1773889601000},"page":"241-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Pathology of Endocrine Gland Tumors"],"prefix":"10.1016","volume":"19","author":[{"given":"Floriana Jessica","family":"Di Paola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Calafato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry Jane","family":"Rhoden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317698376","article-title":"Next-generation sequencing for endocrine cancers: recent advances and challenges","volume":"39","author":"Suresh","year":"2017","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib99","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12022-020-09656-9","article-title":"Genomics and epigenomics in parathyroid neoplasia: from bench to surgical pathology practice","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.path.2026.01.004_bib100","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1677\/ERC-08-0066","article-title":"Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism","volume":"15","author":"Masi","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib101","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.surg.2007.12.012","article-title":"Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations","volume":"143","author":"Sarquis","year":"2008","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.path.2026.01.004_bib102","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib103","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2019-00082","article-title":"Clinical features of multiple endocrine neoplasia type 4: novel pathogenic variant and review of published cases","volume":"104","author":"Frederiksen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.path.2026.01.004_bib104","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/humu.23877","article-title":"Ten years of DICER1 mutations: provenance, distribution, and associated phenotypes","volume":"40","author":"de Kock","year":"2019","journal-title":"Hum Mutat"},{"issue":"13","key":"10.1016\/j.path.2026.01.004_bib105","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MAX and MYC: a heritable breakup","volume":"72","author":"Casco\u0144","year":"2012","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.path.2026.01.004_bib106","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple endocrine neoplasia type 1: latest insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"issue":"10","key":"10.1016\/j.path.2026.01.004_bib75","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1210\/js.2017-00283","article-title":"Harvey cushing treated the first known patient with carney complex","volume":"1","author":"Tsay","year":"2017","journal-title":"J Endocr Soc"},{"issue":"3","key":"10.1016\/j.path.2026.01.004_bib109","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11154-016-9400-1","article-title":"Carney complex: a familial lentiginosis predisposing to a variety of tumors","volume":"17","author":"Stratakis","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/thy.2023.0279","article-title":"Association of the genomic profile of medullary thyroid carcinoma with tumor characteristics and clinical outcomes in an international multicenter study","volume":"34","author":"Xu","year":"2024","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib110","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/GIM.0b013e318216cc6d","article-title":"Multiple endocrine neoplasia type 2: an overview","volume":"13","author":"Moline","year":"2011","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/his.13277","article-title":"Succinate dehydrogenase (SDH)-deficient neoplasia","volume":"72","author":"Gill","year":"2018","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib111","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib112","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0002-9440(10)65563-0","article-title":"Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis","volume":"153","author":"Lubensky","year":"1998","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib113","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/cge.13613","article-title":"Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients","volume":"96","author":"Salama","year":"2019","journal-title":"Clin Genet"},{"issue":"3","key":"10.1016\/j.path.2026.01.004_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12022-013-9276-5","article-title":"Genomic approaches to problems in pituitary neoplasia","volume":"25","author":"Asa","year":"2014","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12022-021-09663-4","article-title":"Genomics and epigenomics of pituitary tumors: what do pathologists need to know?","volume":"32","author":"Asa","year":"2021","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.path.2026.01.004_bib24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Agrawal","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib114","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/PAS.0000000000000368","article-title":"A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma","volume":"39","author":"Chou","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"20","key":"10.1016\/j.path.2026.01.004_bib115","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1200\/JCO.2013.49.6596","article-title":"Remarkable response to crizotinib in woman with anaplastic lymphoma kinase-rearranged anaplastic thyroid carcinoma","volume":"33","author":"Godbert","year":"2015","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.path.2026.01.004_bib116","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1073\/pnas.1321937111","article-title":"Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer","volume":"111","author":"Kelly","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib22","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-25-0104","article-title":"Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells","volume":"14","author":"Calafato","year":"2025","journal-title":"Eur Thyroid J"},{"issue":"10","key":"10.1016\/j.path.2026.01.004_bib32","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1089\/thy.2020.0086","article-title":"Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases","volume":"30","author":"Xu","year":"2020","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/his.14550","article-title":"Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases","volume":"80","author":"Xu","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2026.01.004_bib39","doi-asserted-by":"crossref","unstructured":"De Biase D, Torricelli F, Ragazzi M, et al. Not the same thing: metastatic PTCs have a different background than ATCs. 2018. https:\/\/doi.org\/10.1530\/EC-18-0386.","DOI":"10.1530\/EC-18-0386"},{"issue":"4","key":"10.1016\/j.path.2026.01.004_bib117","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.annonc.2021.12.014","article-title":"Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study","volume":"33","author":"Subbiah","year":"2022","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib118","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI23237","article-title":"Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer","volume":"115","author":"Ciampi","year":"2005","journal-title":"J Clin Investig"},{"issue":"8","key":"10.1016\/j.path.2026.01.004_bib119","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41379-018-0070-2","article-title":"Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT\/\u03b2-catenin pathway","volume":"31","author":"Cameselle-Teijeiro","year":"2018","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2026.01.004_bib120","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1210\/clinem\/dgab025","article-title":"Prevalence and spectrum of DICER1 mutations in adult-onset thyroid nodules with indeterminate cytology","volume":"106","author":"Chong","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib121","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00428-020-02853-1","article-title":"Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations-is the term \u201cthyroblastoma\u201d more appropriate?","volume":"477","author":"Agaimy","year":"2020","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.path.2026.01.004_bib122","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41379-020-0458-7","article-title":"Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations","volume":"33","author":"Chernock","year":"2020","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib123","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/PAS.0000000000001430","article-title":"Recurrent DICER1 hotspot mutations in malignant thyroid gland teratomas: molecular characterization and proposal for a separate classification","volume":"44","author":"Rooper","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib124","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41379-021-00905-8","article-title":"DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma","volume":"35","author":"Gonz\u00e1lez","year":"2022","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/thy.2018.0791","article-title":"GLIS rearrangement is a genomic hallmark of hyalinizing trabecular tumor of the thyroid gland","volume":"29","author":"Nikiforova","year":"2019","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib126","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1172\/JCI84894","article-title":"Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas","volume":"126","author":"Calebiro","year":"2016","journal-title":"J Clin Investig"},{"issue":"4","key":"10.1016\/j.path.2026.01.004_bib127","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/er.2004-0005","article-title":"Molecular pathogenesis of euthyroid and toxic multinodular goiter","volume":"26","author":"Krohn","year":"2005","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib128","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1210\/jc.2003-031225","article-title":"Activating gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a european Collaborative Study","volume":"89","author":"Lumbroso","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.path.2026.01.004_bib129","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/s41379-020-0638-5","article-title":"Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization","volume":"33","author":"Chu","year":"2020","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib130","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/modpathol.2016.115","article-title":"Mammary analog secretory carcinoma of the thyroid gland: a primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion","volume":"29","author":"Dogan","year":"2016","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.path.2026.01.004_bib131","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1089\/thy.2019.0802","article-title":"RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas","volume":"30","author":"Pekova","year":"2020","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.path.2026.01.004_bib132","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/cncr.29887","article-title":"NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States","volume":"122","author":"Prasad","year":"2016","journal-title":"Cancer"},{"issue":"5483","key":"10.1016\/j.path.2026.01.004_bib133","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.289.5483.1357","article-title":"PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]","volume":"289","author":"Kroll","year":"2000","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib134","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0597-64","article-title":"Germline mutations of the PTEN gene in cowden disease, an inherited breast and thyroid cancer syndrome","volume":"16","author":"Liaw","year":"1997","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1092-9134(99)80011-2","article-title":"Thyroid pathologic findings in patients with Cowden disease","volume":"3","author":"Harach","year":"1999","journal-title":"Ann Diagn Pathol"},{"issue":"10","key":"10.1016\/j.path.2026.01.004_bib37","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S1470-2045(25)00399-7","article-title":"Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study","volume":"26","author":"Xing","year":"2025","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib38","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.18632\/oncotarget.22805","article-title":"Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic papillary thyroid carcinomas","volume":"9","author":"Gandolfi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.path.2026.01.004_bib136","article-title":"Exploring the role of TERT in thyroid cancer: a systematic review","volume":"213","author":"Maloberti","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib137","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41379-021-00907-6","article-title":"Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations","volume":"35","author":"Park","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12022-021-09665-2","article-title":"Molecular pathology of poorly differentiated and anaplastic thyroid cancer: what do pathologists need to know?","volume":"32","author":"Volante","year":"2021","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib138","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1122-3","article-title":"A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors","volume":"15","author":"Evangelisti","year":"2015","journal-title":"BMC Cancer"},{"issue":"6447","key":"10.1016\/j.path.2026.01.004_bib139","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/365649a0","article-title":"Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas","volume":"365","author":"Parma","year":"1993","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib47","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular genetic insights into sporadic primary hyperparathyroidism","volume":"26","author":"Brewer","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib57","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/ijc.33166","article-title":"The genomic profile of parathyroid carcinoma based on whole-genome sequencing","volume":"147","author":"Hu","year":"2020","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12022-021-09667-0","article-title":"What did we learn from the molecular biology of adrenal cortical neoplasia? From histopathology to translational genomics","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr Pathol"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib76","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib73","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.path.2026.01.004_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101428","article-title":"Adrenocortical tumorigenesis: lessons from genetics","volume":"34","author":"Kamilaris","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"6018","key":"10.1016\/j.path.2026.01.004_bib77","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib88","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12022-020-09658-7","article-title":"What have we learned from molecular biology of paragangliomas and pheochromocytomas?","volume":"32","author":"Papathomas","year":"2021","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib98","doi-asserted-by":"crossref","first-page":"0072","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","author":"Dahia","year":"2005","journal-title":"PLoS Genet"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1530\/eje.0.1340720","article-title":"Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients","volume":"134","author":"Yang","year":"1996","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic classification of pituitary neuroendocrine tumors","volume":"37","author":"Neou","year":"2020","journal-title":"Cancer Cell"},{"issue":"NOV","key":"10.1016\/j.path.2026.01.004_bib12","article-title":"Identification of novel genes involved in the pathogenesis of an ACTH-secreting pituitary carcinoma: a case report and literature review","volume":"8","author":"Guo","year":"2018","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib13","article-title":"Identification of recurrent USP48 and BRAF mutations in Cushing\u2019s disease","volume":"9","author":"Chen","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.path.2026.01.004_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/js.2017-00364","article-title":"USP8 mutations in pituitary cushing adenomas-targeted analysis by next-generation sequencing","volume":"2","author":"Ballmann","year":"2018","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib15","article-title":"Somatic SF3B1 hotspot mutation in prolactinomas","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-13-0623","article-title":"Non-pheochromocytoma (PCC)\/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC\u2013PGL syndromes: a clinicopathological and molecular analysis","volume":"170","author":"Papathomas","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.path.2026.01.004_bib18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1210\/clinem\/dgaa749","article-title":"Corticotroph aggressive pituitary tumors and carcinomas frequently harbor ATRX mutations","volume":"106","author":"Casar-Borota","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.path.2026.01.004_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12022-018-9521-z","article-title":"Immunohistochemical biomarkers in pituitary pathology","volume":"29","author":"Asa","year":"2018","journal-title":"Endocr Pathol"},{"issue":"12","key":"10.1016\/j.path.2026.01.004_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082619","article-title":"The role of epigenetic modification in tumorigenesis and progression of pituitary adenomas: a systematic review of the literature","volume":"8","author":"Pease","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/jc.2016-2976","article-title":"The history of the follicular variant of papillary thyroid carcinoma","volume":"102","author":"Tallini","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.path.2026.01.004_bib25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoto.2023.1494","article-title":"Prognostic value of preoperative molecular testing and implications for initial surgical management in thyroid nodules harboring suspected (Bethesda V) or known (Bethesda VI) papillary thyroid cancer","volume":"149","author":"Schumm","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"21","key":"10.1016\/j.path.2026.01.004_bib26","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1073\/pnas.0703056104","article-title":"Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors","volume":"104","author":"Gasparre","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038287","article-title":"Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma","volume":"7","author":"Corver","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ccell.2018.06.013","article-title":"Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in H\u00fcrthle cell carcinoma","volume":"34","author":"Gopal","year":"2018","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib30","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/jc.2002-021907","article-title":"RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cncy.22569","article-title":"Copy number variations identified in thyroid FNA specimens are associated with H\u00fcrthle cell cytomorphology","volume":"130","author":"Abi-Raad","year":"2022","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib35","first-page":"252","article-title":"Association of comprehensive thyroid cancer molecular profiling with tumor phenotype and cancer-specific outcomes","volume":"173","author":"Liu","year":"2023","journal-title":"Surgery (United States)"},{"issue":"13","key":"10.1016\/j.path.2026.01.004_bib36","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","article-title":"Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers","volume":"24","author":"Pozdeyev","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12020-020-02283-8","article-title":"Intrapericardial parathyroid carcinoma: a case report","volume":"69","author":"Xin","year":"2020","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib43","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.path.2026.01.004_bib44","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline max mutations: multiple endocrine neoplasia type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.path.2026.01.004_bib45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12022-020-09631-4","article-title":"Hereditary parathyroid disease: sometimes pathologists do not know what they are missing","volume":"31","author":"Turchini","year":"2020","journal-title":"Endocr Pathol"},{"issue":"12","key":"10.1016\/j.path.2026.01.004_bib46","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046325","article-title":"Genome-wide and locus specific alterations in CDC73\/HRPT2-mutated parathyroid tumors","volume":"7","author":"Sulaiman","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.path.2026.01.004_bib49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12022-021-09686-x","article-title":"Analyzing genetic differences between sporadic primary and secondary\/tertiary hyperparathyroidism by targeted next-generation panel sequencing","volume":"32","author":"Hong","year":"2021","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib51","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1210\/jc.2014-1481","article-title":"CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma","volume":"99","author":"Korpi-Hy\u00f6v\u00e4lti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib52","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.path.2026.01.004_bib53","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2265.2007.02894.x","article-title":"Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas","volume":"67","author":"Haven","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib54","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","article-title":"Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?","volume":"156","author":"Cetani","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib55","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","article-title":"Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias","volume":"30","author":"Gill","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas","volume":"2","author":"Pandya","year":"2017","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib59","first-page":"1320","article-title":"p53 abnormalities in human parathyroid carcinoma","volume":"78","author":"Cryns","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib60","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1634\/theoncologist.2018-0334","article-title":"Genomic profiling of parathyroid carcinoma reveals genomic alterations suggesting benefit from therapy","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/path.1489","article-title":"Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma","volume":"202","author":"Haven","year":"2004","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.path.2026.01.004_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/ERC-20-0450","article-title":"Gene expression profile in metastatic and non-metastatic parathyroid carcinoma","volume":"28","author":"Condello","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib63","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/gcc.20895","article-title":"The DNA methylome of benign and malignant parathyroid tumors","volume":"50","author":"Starker","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.path.2026.01.004_bib64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0025-6196(12)61843-6","article-title":"Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"61","author":"CARNEY","year":"1986","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.path.2026.01.004_bib65","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.path.2019.08.005","article-title":"A diagnostic approach to adrenocortical tumors","volume":"12","author":"Hodgson","year":"2019","journal-title":"Surg Pathol Clin"},{"issue":"22","key":"10.1016\/j.path.2026.01.004_bib66","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib67","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.path.2026.01.004_bib69","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1210\/jc.2019-01182","article-title":"Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling","volume":"104","author":"Wannachalee","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib70","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/ERC-20-0128","article-title":"Genomic classification of benign adrenocortical lesions","volume":"28","author":"Faillot","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12672-015-0242-1","article-title":"5th International ACC symposium: classification of adrenocortical cancers from pathology to integrated genomics: real advances or lost in translation?","volume":"7","author":"de Krijger","year":"2016","journal-title":"Horm Cancer"},{"issue":"10","key":"10.1016\/j.path.2026.01.004_bib74","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamaoncol.2019.1558","article-title":"Value of molecular classification for prognostic assessment of adrenocortical carcinoma","volume":"5","author":"Assi\u00e9","year":"2019","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.path.2026.01.004_bib78","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.path.2026.01.004_bib79","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"eLife"},{"issue":"10","key":"10.1016\/j.path.2026.01.004_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jendso\/bvaa123","article-title":"Identification of somatic mutations in CLCN2 in aldosterone-producing adenomas","volume":"4","author":"Rege","year":"2020","journal-title":"J Endocr Soc"},{"issue":"10","key":"10.1016\/j.path.2026.01.004_bib82","doi-asserted-by":"crossref","first-page":"E2093","DOI":"10.1210\/jc.2014-2152","article-title":"Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing\u2019s syndrome: a European multicentric study","volume":"99","author":"Di Dalmazi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.path.2026.01.004_bib83","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.path.2026.01.004_bib84","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1210\/jc.2014-3282","article-title":"Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma","volume":"100","author":"Juhlin","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib85","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib86","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini","year":"2018","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib89","doi-asserted-by":"crossref","first-page":"E2251","DOI":"10.1210\/clinem\/dgaa965","article-title":"Incidence and clinical presentation of pheochromocytoma and sympathetic paraganglioma: a population-based study","volume":"106","author":"Ebbehoj","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.path.2026.01.004_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28332","article-title":"Pheochromocytomas and paragangliomas in children: data from the Italian Cooperative Study (TREP)","volume":"67","author":"Virgone","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.path.2026.01.004_bib91","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1210\/jcem.86.11.8034","article-title":"Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients","volume":"86","author":"Erickson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.path.2026.01.004_bib92","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa039","article-title":"Pheochromocytoma and paraganglioma in children and adolescents: experience of the French society of pediatric oncology (SFCE)","volume":"4","author":"de Tersant","year":"2020","journal-title":"J Endocr Soc"},{"issue":"9","key":"10.1016\/j.path.2026.01.004_bib93","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1200\/JCO.2005.07.198","article-title":"Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD","volume":"23","author":"Dannenberg","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.path.2026.01.004_bib94","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lio2.122","article-title":"Head and neck paragangliomas: a two-decade institutional experience and algorithm for management","volume":"2","author":"Smith","year":"2017","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"26","key":"10.1016\/j.path.2026.01.004_bib95","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1093\/hmg\/dds402","article-title":"Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas","volume":"21","author":"Welander","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.path.2026.01.004_bib96","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/jc.2017-01702","article-title":"SDHC promoter methylation, a novel pathogenic mechanism in parasympathetic paragangliomas","volume":"103","author":"Bernardo-Casti\u00f1eira","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2026.01.004_bib97","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mce.2017.07.018","article-title":"Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome","volume":"469","author":"Settas","year":"2018","journal-title":"Mol Cell Endocrinol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918126000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918126000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:00:07Z","timestamp":1784530807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918126000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1875918126000048"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2026.01.004","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Pathology of Endocrine Gland Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}